Clinical trial
A Retrospective Observational Study on Weight Change, Effectiveness, and Safety Following Switching to Lurasidone in Korean Patients With Bipolar Disorder Under Routine Clinical Practice
NCT07834112 is registered in ClinicalTrials.gov with Dong-Wook Kim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Observational Study on Weight Change, Effectiveness, and Safety Following Switching to Lurasidone in Korean Patients With Bipolar Disorder Under Routine Clinical Practice
- Lead sponsor
- Dong-Wook Kim
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 9, 2024
- Completion date
- December 31, 2025
- Enrollment
- 155 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar disorder (bd)